Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Schiller
Ampronix

Predicting Heart Attack Risk with CT Angiography

By Medimaging International staff writers
Posted on 25 Feb 2013
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of myocardial infarctions and other abnormal cardiac events in patients with suspected coronary artery disease (CAD) but no treatable risk factors, such as high blood pressure or high cholesterol.

“CCTA should be considered as an appropriate first-line test for patients with atypical chest pain and suspected but not confirmed coronary artery disease,” said the study’s lead author, Jonathon Leipsic, MD, FRCPC, from the University of British Columbia (Vancouver, BC, Canada).

Treatment for heart disease typically involves tackling modifiable cardiovascular risk factors such as high blood pressure, elevated cholesterol, diabetes, and smoking. However, some risk factors, such as family history, are not modifiable, and no risk models exist to help guide clinicians to identify those symptomatic patients without cardiac risk factors who are at an increased risk of death and myocardial infarction. “This scenario, where patients are symptomatic but have no cardiac risk factors, comes up often in clinical practice,” Dr. Leipsic said. “We lack a good tool to stratify these patients into risk groups.”

CCTA is a noninvasive test that has shown high accuracy for the diagnosis or exclusion of coronary artery disease in individuals. However, referral for patients with suspected coronary artery disease is frequently based on clinical risk factor scoring. Less is known about the prognostic benefits of CCTA in individuals with no medically modifiable risk factors.

In the first study of its sort, published online February 2013 in the journal Radiology, Dr. Leipsic and colleagues correlated CCTA results with the risk of major adverse cardiac events in 5,262 patients with suspected coronary artery disease but no medically modifiable risk factors. They culled the data from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) registry.

After a median follow-up of 2.3 years, 104 patients had experienced a major adverse cardiovascular event. The researchers identified a high occurrence of CAD in the study group, in spite of the lack of modifiable risk factors. More than 25% of the patients had non-obstructive disease or disease related to the accumulation of plaque in the arteries, and another 12% had obstructive disease with a greater than 50% narrowing in a coronary artery. “We found that patients with narrowing of the coronary arteries on CT had a much higher risk of an adverse cardiac event,” Dr. Leipsic said. “This was true even for those without a family history of heart disease.”

Both asymptomatic and symptomatic patients with obstructive disease faced an increased risk for a major cardiac event. Contrarily, the absence of CAD on CCTA was associated with a very low risk of a major event.

The findings, according to the investigators, emphasize the need for improvement in the evaluation of individuals who may be overlooked by conventional techniques of CAD assessment. “If a patient shows up with vague symptoms and no medically modifiable risk factors, doctors often dismiss them or do a treadmill test, which won’t identify atherosclerosis and only has a modest sensitivity for detecting obstructive disease,” Dr. Leipsic said.

CCTA could help address this problem, Dr. Leipsic added, by helping to detect or rule out coronary artery disease and identifying those who may be helped with more intensive therapy. The researchers continue to examine the CONFIRM data with the goal of further clarifying the association between plaque and myocardial infarctions and the longer-term outlook for patients with coronary artery disease.

“We are now collecting data to determine the prognostic value of CCTA after five years or more of follow-up, which will be very important for the field,” Dr. Leipsic stated.

Related Links:
University of British Columbia



Channels

MRI

view channel
Image: The ViewRay MRIdian System (Photo courtesy of ViewRay).

Unique MRI-Guided Radiation Therapy System Showcased at ESTRO 2015

ViewRay (Cleveland OH, USA) has demonstrated their advanced radiation therapy technology for the treatment of cancer at the April, 2015, European Society for Therapeutic Radiology and Oncology (ESTRO)... Read more

Ultrasound

view channel

Ultrasound Device Reduces the Number of Tests Required for Inpatients and Outpatients

The results of a study carried out by the European Association for the Study of the Liver (EASL; Geneva, Switzerland) into the use of a Pocket-sized Ultrasound Device (PUD) together with a physical examination, have been presented at the 2015 International Liver Congress, in Vienna (Austria). The study evaluated the... Read more

Nuclear medicine

view channel
Image: PET scan images (Courtesy of King’s College London).

Preventing Unnecessary Radiotherapy for Patients with Early-Stage Hodgkin’s Lymphoma

A new study suggested that patients with early-stage (stage 1a or 2a) Hodgkin’s lymphoma disease, who underwent three cycles of chemotherapy with the drugs doxorubicin, bleomycin, vinblastine, and dacarbazine... Read more

General/Advanced Imaging

view channel

Global Healthcare Study of Coronary Artery Disease Reaches Significant Milestone

A major milestone has been reached in the Lipid-Rich Plaque (LRP) study, a prospective, multicenter clinical trial with the potential to reveal breakthrough correlations between Lipid-Rich Plaques and occurrence of heart attacks. The LPR study has now enrolled 1,000 patients, and aims to identify a correlation between... Read more

Imaging IT

view channel

Childhood Radiation Exposure Can Be Reduced Significantly Using EMR Decision Support

The results of a study to find ways to reduce the pediatric radiation burden have been published in the May 8, 2015, issue of the Journal of the American Board of Family Medicine. The study included 115 physicians from 17 US military family medicine training programs, and aimed to find whether an existing clinical decision... Read more

Industry News

view channel

Medical Imaging Company Recognized for Focus on Customer Partnerships

A company is recognized for excellence in its growth strategy and implementation, a high degree of product and technology innovation, and leadership. Frost & Sullivan (Mountain View, CA, USA) has awarded the 2015 North American Frost & Sullivan Medical Imaging Company of the Year award to Toshiba America Medical... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.